×
-0.016734279918864 -0.016734279918864 -0.0238336713995943 -0.0238336713995943 -0.0603448275862068 -0.106237322515213 -0.0947008113590264 -0.0689655172413793
Stockreport

UPDATE 1-India's Dr. Reddy's Q3 profit tumbles, hit by U.S. pricing pressure [Reuters (UK)]

DR REDDY LABS (RDY)  More Company Research Source: Reuters
US:NYSE Investor Relations: drreddys.com/investors
PDF India's Dr. Reddy's third-quarter profit tumbles, hit by U.S. pricing pressure | Reuters Reuters Staff 2 Min Read (Reuters) - Indian generic drugmaker Dr. Reddy’s Laboratories Ltd said quarterly net profit slumped nearly 40 percent, its third consecutive quarter of declines as pricing pressures in the United States hit sales. Indian drugmakers have faced challenges in negotiating prices as a result of consolidation among drug distributors in the United States, the world’s biggest pharmaceuticals market. Like many of its domestic rivals, Dr Reddy’s has also been hit by U.S. bans on Indian plants over quality control issues. Net profit fell 38.5 percent to 3.03 billion rupees ($47.7 million) in the third quarter ended Dec. 31, below an average analyst estimate of 3.4 billion rupees. Revenue from the company’s generics business in North America fell 3 percent to 16.07 billion rupees. Revenue from its Europe generics business dropped 7 percent to 2.01 billion rupees due to pricing pressur [Read more]

IMPACT SNAPSHOT EVENT TIME: RDY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS